HF-DACH 2018, Cardiac fibrosis marker GDF-15 is associated with prognosis in treatment naive cancer patients

26 May 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Henrike Arfsten

Medical University of Vienna, Vienna (Austria)

9 More presentations in this session

Presentation thumbnail

Cytokines, Epicardial Adipose Tissue and Diastolic Function in the General Population

Associate Professor R. Hullin (Lausanne, CH)

Presentation thumbnail

The BNP genetic variant rs198389: cardiovascular phenotype and risk in stage A/B heart failure subjects from the STOP-HF Trial

Doctor V. Cannone (Parma, IT)

Abstract Slides Video

Presentation thumbnail

Neurohormonal function across categories of systolic dysfunction in chronic heart failure

Doctor A. Aimo (Pisa, IT)

Abstract Slides Video

Presentation thumbnail

BNP in patients with severe aortic valve stenosis undergoing valve replacement: pathophysiological determinants and long-term impact on mortality

Doctor L. Weber (CH)

Abstract Slides Video

Presentation thumbnail

Elevated suppression of tumorigenicity 2 associated with poor outcome in heart failure with preserved ejection fraction

Doctor C. Roy (La Louviere, BE)

Abstract Slides Video

Access the full session

Session thumbnail

Diagnostics - From epicardial fatty tissue to biomarkers and echocardiography

The Event

Heart Failure 2018

26 May - 29 May 2018

You may be interested in

Congress Presentation

The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure

Congress Presentation

Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation

Congress Presentation

Novel biomarkers reveal distinct biological phenotypes in heart failure with preserved vs reduced ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources